Equities

Fuji Pharma Co Ltd

Fuji Pharma Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,373.00
  • Today's Change32.00 / 2.39%
  • Shares traded130.90k
  • 1 Year change-4.79%
  • Beta0.7476
Data delayed at least 20 minutes, as of Nov 14 2024 05:09 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue46,13840,88935,426
OPERATING EXPENSES
Cost of revenue total28,29424,37420,867
Selling, general and admin. expenses, total9,2318,3317,355
Depreciation/amortization1,3311,141941
Unusual expense(income)(1345)(244)288
Other operating expenses, total--1.001.00
Total operating expense--36,78731,937
Operating income--4,1023,489
Other, net5420041
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes8,2764,3993,723
Provision for income taxes2,1289631,026
Net income after taxes--3,4362,697
Minority interest000
Net income before extra. Items--3,4362,697
Total extraordinary items------
Net income6,1463,4362,697
Inc.avail. to common excl. extra. Items--3,4352,696
Inc.avail. to common incl. extra. Items6,1463,4352,696
EPS RECONCILIATION
Basic/primary weighted average shares242424
Basic/primary eps excl. extra items253141111
Basic/primary eps incl. extra items253141111
Dilution adjustment------
Diluted weighted average shares242424
Diluted eps excl. extra items253141111
Diluted eps incl. extra items253141111
COMMON STOCK DIVIDENDS
DPS - common stock primary issue--3735
Gross dividend - common stock--899850
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental19610777
SUPPLEMENTAL INCOME
Depreciation, supplemental3,3432,7072,462
Total special items--72571
NORMALISED INCOME
Normalized income before taxes--4,4714,294
Effect of special items on income taxes--(53)79
Income tax excluding impact of special items--9101,105
Normalized income after tax--3,5613,189
Normalized income avail. to common--3,5603,188
Basic normalized EPS--147131
Diluted normalized EPS--147131
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.